Late-Breaking MagSense® Safety Study Abstract Accepted for AACR 2018

Imagion Biosystems' abstract "Detection of HER2+ tumor cells using MagSense® nanoparticles: safety and sensitivity" has been accepted for the 2018 AACR meeting…


Imagion Biosystems Appoints Dr Farideh Bischoff as Vice President of Clinical Research

Cancer diagnostics industry veteran will lead first-in-human clinical trial program Imagion Biosystems is pleased to announce the appointment of Farideh…


Imagion Biosystems Launches New PEG-Coated Iron-Oxide Nanoparticles for Life Science Research Applications

Slow rate of clearance makes new product ideal for magnetic particle imaging. Imagion Biosystems Limited (ASX:IBX), a company dedicated to improving healthcare…


Imagion Biosystems Secures Nanoparticle Manufacturer

Imagion Biosystems Limited (Imagion, ASX:IBX) has entered into a Master Service Agreement with ChemConnection BV, a Dutch contract manufacturing organization…


Pre-clinical Data Presented at the 2017 World Medical Imaging Congress Move MagSense® Closer to the Clinic

"Specific Detection of HER-2 positive tumors in mice using superparamagnetic relaxometry" is the title of a poster presented by Erika Vreeland, PhD, at the…


New mPEG-coated Nanoparticles Clear Slowly from Blood Circulation

At the April 2017 Annual Meeting of the American Association for Cancer Research, we first reported our long-circulating mPEG-coated PrecisionMRX®…


Magnetic Relaxometry for Cancer Detection

In this second segment of Bob Proulx's presentation to investors at the 2016 NobleCon meeting, he answers the question of how magnetic relaxometry might be…


Introduction to Magnetic Relaxometry

This video (below) captures the opening minutes of CEO Bob Proulx's address to the 2016 NobleCon meeting, where he outlines the medical need for a new cancer…



Notice: Undefined index: file in /nas/content/live/imagionbx/wp-includes/media.php on line 1676

Imagion Biosystems Initiates MagSense® Instrument Development

Imagion Biosystems Limited (Imagion, ASX:IBX) has entered into a Service Agreement with StarFish Medical ("StarFish"), Canada's largest medical device design,…


Imagion Biosystems at BIO 2017

The 2017 International Convention of BIO, the Biotechnology Innovation Organization, was held June 19-22 in San Diego. More than 16,000 individuals attended…